Who owns AVALO THERAPEUTICS INC?
- CUSIP Number: 05338f207
Tip: Access positions for across all investors
Analyze quarterly positions in Avalo Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avalo Therapeutics stock
Who bought or sold AVALO THERAPEUTICS INC this quarter?
There are no current stakeholders of Avalo Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Avalo Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Acadian Asset Management | Sep 2023 | 283k | $34k |
| Geode Capital Management | Sep 2023 | 134k | $16k |
| BlackRock | Sep 2023 | 105k | $13k |
| Tower Research Capital | Sep 2023 | 50k | $6.0k |
| Susquehanna International | Sep 2023 | 23k | $2.7k |
| XTX Topco | Sep 2023 | 19k | $2.2k |
| Northern Trust | Sep 2023 | 11k | $1.3k |
| Morgan Stanley | Sep 2023 | 11k | $1.3k |
| Group One Trading | Sep 2023 | 174.00 | $21.001800 |